New treatment option for Preeclampsia
Official title Prenatal Aspirin and Postpartum Vascular Function
ClinicalTrials.gov ID: NCT05653973
What this study is testing
What is Acetylcholine?
Acetylcholine is an investigational medicine, given as an once-daily, being studied as a potential treatment for preeclampsia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Preeclampsia is a pregnancy disorder affecting \~5-10% of pregnancies in the United States. Women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life, even if they are otherwise healthy.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only. Healthy volunteers may be eligible.
You may be able to join if
- Inclusion:
- 18 years or older,
- 12 weeks to 5 years postpartum
- and one of the following:
- women who had a normal pregnancy and did not use low does aspirin (LDA) during pregnancy,
See the full eligibility criteria
- Inclusion:
- 18 years or older,
- 12 weeks to 5 years postpartum
- and one of the following:
- women who had a normal pregnancy and did not use low does aspirin (LDA) during pregnancy,
- women who had a normal pregnancy and used LDA during pregnancy,
- women who had preeclampsia and did not use LDA during pregnancy,
- women who had preeclampsia and used LDA during pregnancy. Exclusion:
- current daily aspirin use,
- skin diseases,
- current tobacco use,
- diagnosed or suspected hepatic or metabolic disease including chronic kidney disease (CKD) defined as reduced eGFR \< 60 mL/min/1.73m2,
- statin or other cholesterol-lowering medication,
- current antihypertensive medication,
- history of hypertension prior to pregnancy,
- history of gestational diabetes,
- current pregnancy,
- body mass index \<18.5 kg/m2,
- allergy to materials used during the experiment.(e.g. latex),
- known allergies to study drugs.
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.